Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cathepsin L pseudogene (ENSG00000234460) is a genomic DNA sequence resembling the cathepsin L gene but is classified as a pseudogene, meaning it is transcriptionally inactive and does not encode a functional protein product. Cathepsin L itself is an important cysteine protease involved in lysosomal protein degradation, antigen presentation, and other cellular processes, and dysregulated cathepsin L activity has been implicated in diseases including cancer and viral entry. However, the pseudogene variant contains disabling mutations or lacks regulatory features essential for functional expression. There is no evidence that this pseudogene is a therapeutic target or has direct biological or clinical relevance. Additional Context: - Functional cathepsin L (CTSL) is a classical cysteine protease in the endopeptidase family, but the pseudogene does not function in this capacity. - Pseudogenes, such as "cathepsin L pseudogene," often arise from gene duplication or retrotransposition events and generally do not have functional protein products, though in rare cases some may regulate related genes via non-coding RNA roles—no such functions are established for ENSG00000234460. - Drug discovery efforts focus on the protein-coding "cathepsin L" (gene symbol CTSL or CTSL1 in humans), not on pseudogenes. If structured information is required for a true therapeutic target, refer to the functional protein "cathepsin L" or "cathepsin L1" (gene: CTSL, Ensembl: ENSG00000135047), not the pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cathepsin L pseudogene.